Trial intelligence / Profile preview

Nicotine Lozenge vs Nicotine Patch for Smoking Cessation

NCT00365508Phase 4Completed

Sponsor
Fox Chase Cancer Center
Start
Feb 2006
Primary completion
Aug 2009
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD), sponsored by Fox Chase Cancer Center. Started Feb 2006; status: completed.

02

Drugs

nicotine patch
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00365508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00365508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call